The Patent Finder

Aralez Pharmaceuticals Canada Inc.

Also on record
Records under this name other than the patents Aralez Pharmaceuticals Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 7 of 7 · Back to Aralez Pharmaceuticals Canada Inc.

PatentTitleStatus Expires Confidence
US 9,861,579Foamable Formulation
Lapsed on the fee record
Ended Jan 9, 2026 · High confidence
Lapsed on the fee recordEnded Jan 9, 2026High confidence
US 7,772,210Cystitis Treatment with High Dose Chondroitin Sulfate
Term ended
Term ended Nov 7, 2024 · High confidence
Term endedTerm ended Nov 7, 2024High confidence
US 10,646,441Foamable Formulation
Lapsed on the fee record
Ended May 12, 2024 · High confidence
Lapsed on the fee recordEnded May 12, 2024High confidence
US 8,084,441Cystitis Treatment with High Dose Chondroitin Sulfate
Term ended
Ended no later than Feb 19, 2023 · Low confidence
Term endedEnded no later than Feb 19, 2023Low confidence
US 8,334,276Cystitis Treatment with High Dose Chondroitin Sulfate
Term ended
Term ended Feb 19, 2023 · High confidence
Term endedTerm ended Feb 19, 2023High confidence
US 8,778,908Cystitis Treatment with High Dose Chondroitin Sulfate
Term ended
Term ended Feb 19, 2023 · High confidence
Term endedTerm ended Feb 19, 2023High confidence
US 6,083,933Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
Term ended
Term ended Apr 19, 2019 · From the USPTO record
Term endedTerm ended Apr 19, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited